ARTICLE
Auteur(s) : Clara De Simone, Teresa Sisto, Selenia
Vallone, Angelo Carbone,
Maurizio Rotoli, Pierluigi Amerio
Department of Dermatology, Catholic University
of the Sacred Heart, Largo Gemelli 8, 00168 Rome
Italy
Electroporation produces transient hydrophilic pores across cell
membranes through application of short electric field pulses. The
pores allow the passage of macromolecules through a combination of
diffusion, electrophoresis and electro-osmosis. Skin
electroporation with short, high-voltage pulses (0.3-1.0 V)
increases permeability of the stratum corneum, enhancing
percutaneous drug delivery [1]. We describe a 60-year-old Caucasian
woman with a granulomatous reaction arising after transdermal
permeation of a gel for facial skin rejuvenation by
electroporation. The patient presented with a 20-day history of
bilateral erythematous infiltrated plaques in the glabellar,
periorbital and perioral areas, associated with intense pain and
fever (38.5 °C) (figure 1A). Forty days
previously, a carnitine and creatine gel had been permeated on her
face via electroporation. The patient had been treated at another
hospital with systemic prednisone (60 mg/day), suspended after
one week because of severe and treatment-resistant arterial
hypertension (200-100 mmHg). When she came to our observation she
had mild leukocytosis (16.70 × 109/L) with an elevated
neutrophil count (80%). Magnetic resonance study of the face
excluded bone inflammation. An erysipelas was hypothesized, but
systemic treatment with ceftriaxone, teicoplanin and vancomycin was
ineffective. Histological examination of a skin biopsy from the
glabellar region showed an inflammatory granulomatous dermal
infiltrate with foamy histiocytes, suggestive of foreign body
granuloma (figures 1C,
D). Cultures for common aerobic and anaerobic germs were
negative. Ziehl-Nielsen acid fast staining and PAS staining
excluded mycobacterial and fungal infections. Reports of the
anti-inflammatory efficacy of tetracyclines in similar cases of
granulomatous reactions [2, 3] prompted treatment with doxycycline
100 mg/d, associated with nimesulide, a well known
antinflammatory drug, at a dosage 100 mg/d. After a month, the
cutaneous lesions were considerably improved and the systemic
symptoms (body temperature, leukocytosis) normalized. At a
six-month follow-up complete resolution of the skin lesions was
observed (figure
1B). Electroporation has a variety of applications in
relation to the diverse substances that can be delivered, e.g.
dyes, heavy metal ions, gene segments, antibodies, enzymes, and
drugs. Dermatological applications comprise transdermal delivery of
cytotoxic drugs to treat cutaneous tumours and cosmetics to improve
aesthetic appearance [4]. Granulomatous reactions after
subcutaneous injection of filler materials, such as hyaluronic
acid, polylactic acid, bovine or human-derived collagen, and
polymerized silicones have been widely reported [2]. Treatment
includes topical, intralesional, and systemic corticosteroids,
topical tacrolimus and imiquimod, intralesional 5-fluorouracil, and
systemic isotretinoin, cyclosporine, allopurinol, colchicines, and
tetracyclines [2]. Surgical intervention is recommended for
circumscribed nodular lesions. The most significant side effects of
skin electroporation are a painful sensation due to direct electric
stimulation of underlying nerves and muscles and transient erythema
caused by a temporary increase in blood flow [5]. Foreign body
granuloma due to transdermal permeation of drugs or cosmetic gels
by electroporation has never been described. We hypothesized that
adulterated substances or contaminating agents delivered through
electroporation could be responsible for the inflammatory response.
Nevertheless its exact mechanism is unclear and no other substances
except for creatine and carnitine were reported on the product
summary. We used an association of doxycycline and nimesulide at
dosage of 100 mg/d each in order to obtain a combined
anti-inflammatory effect with lower doses than those usually
administered.
The patient’s complete response suggests that the combination
may be effective in treating cutaneous foreign body granuloma
induced by cosmetic procedures. Since various materials and
techniques have come into use for cosmetic or reconstructive
purposes, further investigation into the ingredients that may cause
adverse reactions is needed. In addition, patients should be
adequately informed of the chemicals used and the administration
techniques applied and give their written consent to the procedure.
Although electroporation for aesthetic purposes is becoming
increasingly popular, only experienced physicians should perform
these interventions [6].
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Denet AR, Vanbever R, Préat V. Skin
electroporation for transdermal and topical delivery. Adv Drug
Deliv Rev 2004; 56: 659-74.
2 Lloret P, Espana A, Leache A, et al.
Successful treatment of granulomatous reactions secondary to
injection of esthetic implants. Dermatol Surg 2005; 31: 486-90.
3 Senent P, Bachelez H, Ollivaud L, et al.
Minocycline for the treatment of cutaneous silicone granulomas. Br
J Dermatol 1999; 140: 985-7.
4 Ti-Fei Y. Electroporation: an arsenal of application.
Cytotechnology 2007; 54: 71-6.
5 Prausnitz MR. The effects of electric current applied to
the skin: a review for transdermal drug delivery. Adv Drug Deliv
Rev 1996; 18: 395-425.
6 Kerscher M. Aesthetic and cosmetic dermatology. Eur J
Dermatol 2009; (in press).
|